18TH ANNUAL PAIN THERAPEUTICS SUMMIT

Oct 28 – Oct 29, 2024

Financial Results

Select Year:
August 12, 2026 12:00 AM ETQ2 Quarterly results 2026
May 14, 2026 12:00 AM ETQ1 Quarterly results 2026
December 31, 2025 12:00 AM ETAnnual report 2025
November 13, 2025 12:00 AM ETQ3 Quarterly results 2025
August 14, 2025 12:00 AM ETQ2 Quarterly results 2025
May 14, 2025 12:00 AM ETQ1 Quarterly results 2025
December 31, 2024 12:00 AM ETAnnual report 2024
November 12, 2024 12:00 AM ETQ3 Quarterly results 2024
August 13, 2024 12:00 AM ETQ2 Quarterly results 2024
May 13, 2024 12:00 AM ETQ1 Quarterly results 2024
December 31, 2023 12:00 AM ETAnnual report 2023
November 13, 2023 12:00 AM ETQ3 Quarterly results 2023
September 15, 2023 12:00 AM ETQ2 Quarterly results 2023


You are about to review presentations, reports and/or filings of MIRA Pharmaceuticals, Inc., that contain time-sensitive information. The information contained therein is only accurate as of the date thereof. MIRA Pharmaceuticals, Inc. will not be reviewing or updating the material that is contained in these items after the date thereof. The information contained therein may be updated, amended, supplemented or otherwise altered by subsequent presentations, reports and/or filings by MIRA Pharmaceuticals, Inc.

Revoke Consent